Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT05033457
Enrolling by invitation Observational

Comparative Study Between UBE and PETD for the Treatment of Lumbar Spinal Canal Stenosis

NCT05033457 · tracked via the Priya Life Science China tracker
Sponsor
Shaanxi Provincial People's Hospital
Phase
Observational
Started
2018-01-01
Last updated
2021-09-02

Condition(s) studied

Lumbar Disc Herniation

Investigational drug(s) / intervention(s)

unilateral biportal endoscopy technique or percutaneous endoscopic transforaminal discectomy

unilateral biportal endoscopy technique or percutaneous endoscopic transforaminal discectomy: Treatment of lumbar intervertebral disc herniation with unilateral biportal endoscopy technique in unilateral biportal endoscopy technique group.Treatment of lumbar intervertebral disc herniation with percutaneous endoscopic transforaminal discectomy in percutaneous endoscopic transforaminal discectomy group.

Study summary

OBJECTIVE Both unilateral biportal endoscopy technique(UBE) and percutaneous endoscopic transforaminal discectomy(PETD) are minimally invasive and effective surgical procedures for lumbar spinal stenosis.The object of this retrospective study was to compare the clinical and radiological outcomes between UBE and PETD.

METHODS In the period from July 2020 to December 2020, using UBE or PETD to treat lumbar canal stenosis.Patients were classified into two groups based on the surgery they had undergone. Preoperative and postoperative MR image was used to evaluate the removal rate of lumbar disc herniated material by two surgical methods. The two surgical methods are also compared and evaluated in terms of operation time, incision size, hospitalization time, etc.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: \- Single-segment lumbar disc herniation/lumbar spinal stenosis Exclusion Criteria: * Multi-segment lumbar disc herniation / lumbar spinal stenosis、Have received surgery、Hypertension、Diabetes Inclusion Criteria: Inclusion Criteria: Single-segment lumbar disc herniation Symptoms of nerve compression Exclusion Criteria: foraminal and extraforaminal disc herniation multilevel disc herniation, spinal stenosis spondylolisthesis scoliosis prior lumbar surgery spinal infection spinal tumor a history of hip or knee arthritis

Primary outcome measure(s)

  • Cross-sectional area of the preoperative lumbar intervertebral disc — preoperative
    The preoperative axial T2-weighted MRI slices of the patient can be used to measure the cross-sectional area of the intervertebral disc of the diseased segment.
  • Cross-sectional area of the preoperative spinal canal — preoperative
    The preoperative axial T2-weighted MRI slices of the patient can be used to measure the cross-sectional area of the spinal canal of the diseased segment.
  • Cross-sectional area of the postoperative lumbar intervertebral disc — 3 months after surgery
    The postoperative axial T2-weighted MRI slices of the patient can be used to measure the cross-sectional area of the intervertebral disc of the diseased segment.
  • preoperative ODI — preoperative
    According to the Oswestry Disability Index (ODI), evaluate the preoperative ODI of participants.
  • ODI on 3 months after operation — 3 months after surgery
    According to the Oswestry Disability Index (ODI), evaluate the ODI of participants on 3 months after operation.
  • ODI at the final follow-up — Final follow-up
    According to the Oswestry Disability Index (ODI), evaluate the ODI of participants at the final follow-up.
  • preoperative VAS back pain score — preoperative
    According to the visual analog scale (VAS) scoring standard, assess the preoperative VAS back pain score of participants.
  • preoperative VAS leg pain score — preoperative
    According to the visual analog scale (VAS) scoring standard, assess the preoperative VAS leg pain score of participants.
  • VAS back pain score on postoperative day 1 — 1 day after operation
    According to the visual analog scale (VAS) scoring standard, assess the VAS back pain score of participants on postoperative day 1.
  • VAS leg pain score on postoperative day 1 — 1 day after operation
    According to the visual analog scale (VAS) scoring standard, assess the VAS leg pain score of participants on postoperative day 1.
  • VAS back pain score on 3 months after operation — 3 months after operation
    According to the visual analog scale (VAS) scoring standard, assess the VAS back pain score of participants on 3 months after operation.
  • VAS leg pain score on 3 months after operation — 3 months after operation
    According to the visual analog scale (VAS) scoring standard, assess the VAS leg pain score of participants on 3 months after operation.
  • VAS back pain score at the final follow-up — Final follow-up
    According to the visual analog scale (VAS) scoring standard, assess the VAS back pain score of participants at the final follow-up.
  • VAS leg pain score at the final follow-up — Final follow-up
    According to the visual analog scale (VAS) scoring standard, assess the VAS leg pain score of participants at the final follow-up.

Trial sites (1)

FacilityCityRegionStatus
Shanxi Medical University Taiyuan Shanxi

More Shaanxi Provincial People's Hospital trials in China

Coronary Arterial Microcirculation and Metabolism Enrolling by invitation

Other trials for the same condition

Brain Connectomic Mechanisms of Spinal Manipulative Therapy on LDH Analgesia Based on Multimodal MRI Starting soon
The Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation Recruiting
A Biomechanical Study of the Lumbar Intervertebral Disc by Lever Positioning Manipulation Recruiting
Effect of Irrigation Pressure on Postoperative Complications and Surgical Field Clarity in Unilateral Biportal Endoscopic Surgery Recruiting
Cortical Surface Functional Changes After Lever Positioning Manipulation for Lumbar Disc Herniation Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05033457 on ClinicalTrials.gov ↗ ← All trials in China